KPL: Drug production must be exempt from power constraints

- Currently, neither pharmaceutical wholesalers nor drug manufacturers are covered by critical infrastructure. That is, when the power is cut, wholesalers do not work, manufacturers stop producing," warned Lukasz Pietrzak, Chief Pharmaceutical Inspector at the Innovators Forum in Warsaw.

According to the law, the Polish Power Grid (PSE), in the event of a shortage of power for electricity production, can limit the supply of electricity to the largest energy consumers, which means industrial plants first. The last time such power levels were announced was in August 2015.

Meanwhile, pharmaceutical production and distribution in Poland is highly dependent on energy supplies. Each plant has a vari...